Evidence-led education. Independently researched. Medically reviewed content clearly labeled.
Live Wellness

Side-effect support

Managing Nausea on a GLP-1 Medication

Practical, conservative strategies for common gastrointestinal symptoms—and signs that require medical help.

Updated July 28, 2026 8 min read

Nausea is common, especially during dose escalation. Smaller meals, slower eating, hydration and clinician-guided dose decisions may help, but persistent or severe symptoms need medical evaluation.

What to know

  • Eat slowly and stop at comfortable fullness.
  • Contact your prescriber before changing a dose.
  • Severe abdominal pain, inability to keep fluids down or dehydration needs prompt care.

Start with meal size

Large, high-fat meals may feel harder to tolerate when stomach emptying is slower. Try smaller portions and pause between bites. Bland, lower-fat foods may be easier during a short flare.

Protect hydration

Sip fluids throughout the day rather than drinking a large volume at once. Ongoing vomiting or diarrhea can cause dehydration and kidney problems, so call your care team if fluid intake is not keeping up.

Know when to escalate

Seek urgent medical advice for severe or persistent abdominal pain, especially if it reaches the back; signs of dehydration; fainting; allergic reaction; or vomiting that prevents fluid intake.

Look for patterns instead of banning foods

Note when symptoms occur, what and how much you ate, fluid intake, and where you are in the dosing schedule. A short record can help a prescriber or dietitian separate a repeatable trigger from a one-off difficult day.

Keep nutrition simple during a flare

Choose small portions of foods you already tolerate and avoid forcing a full meal. As symptoms settle, return to a more varied pattern rather than allowing a temporary low-intake menu to become the long-term default.

Do not adjust the prescription on your own

Dose timing and escalation are clinical decisions. Contact the prescribing team if nausea is interfering with eating, drinking, work, sleep, or taking other necessary medicines; they can assess symptoms and the next appropriate step.

Sources

  1. Ozempic prescribing information — U.S. Food and Drug Administration (2026-05)
  2. Wegovy prescribing information — U.S. Food and Drug Administration (2025-12)
  3. Mounjaro prescribing information — U.S. Food and Drug Administration (2026)
  4. Zepbound prescribing information — U.S. Food and Drug Administration (2026-02)

Continue learning